4) The growing use of atypical
antipsychotic has reduced the incidence of NMS5 and it is estimated that 0.
Methods: Demographics of patients, type of exposure, distribution according to the reason, the amount of the exposed antipsychotics, clinical findings, the length of hospital stay, and the outcome of the patients in typical and atypical
antipsychotic exposures were analyzed.
The technology for which Sysmex was awarded this years commendation focuses on the fact that atypical
white blood cells contain more RNA than normal white blood cells.
polypoid adenomyoma (APA) is a rare uterine lesion first described in 1981.
fractures occur with little or no force or trauma.
Melanocytic Naevi (AMN --Aka : Atypical
Mole, dysplastic naevi).
fibroxanthoma presents as a dermally based, circumscribed lesion with overlying epidermal collarette, central ulceration, and parakeratosis (Figure 1, A and B).
93%) were diagnosed with atypical
glandular hyperplasia transformation of adenomyosis.
Breaking and a slightly radiolucent line were observed in the lateral subtrochanteric femoral cortex, and she was diagnosed with atypical
incomplete subtrochanteric femoral fracture (Figure 1(a)).
The patient is an adult female with a past medical history of atypical
HUS (aHUS), treated with therapeutic plasma exchange (TPE) on multiple occasions with good response.
5% of children treated with two or more drugs received two atypical
antipsychotics, and 0.
Authors Elder and Yun present students, academics, and medical professionals working in a wide variety of contexts with a guide to the diagnosis of melanomas and atypical
USPRwire, Tue Sep 08 2015] Global Markets Direct's, 'Atypical
Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome) - Pipeline Review, H2 2015', provides an overview of the Atypical
Hemolytic Uremic Syndrome (Nondiarrhea- Associated Hemolytic Uremic Syndrome)'s therapeutic pipeline.
Women with atypical
hyperplasia are at increased risk for breast cancer.
United States-based Alexion Pharmaceuticals has received final positive recommendation from the UK's National Institute for Health and Care Excellence (NICE) for national commissioning of its Soliris (eculizumab) for all patients in England suffering from atypical
haemolytic uremic syndrome, it was reported on Friday.